← Leaderboards
Joseph A Pidala
Medical College Of Wisconsin
$4,470,460
Attributed
$6,363,297
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
FDA$3,534,762 · 1
NIH$2,828,535 · 4
By mechanism
R01$4,091,292 · 2
UG1$1,850,842 · 1
R21$250,913 · 1
R03$170,250 · 1
Top collaborators
- Stephanie J Lee5 shared
- Brent R Logan2 shared
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- Xue-Zhong Yu$18,834,259
- Robert L Truitt$1,772,126
- Nirav Shah$837,600
Others in their field
Top investigators on “Transplantation”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Mary M Horowitz · Medical College Of Wisconsin$224,924,548
- Craig B Thompson · Sloan-Kettering Inst Can Research$157,997,949
- Charles A Coltman · Southwest Oncology Group$141,983,231
- Richard L Schilsky · University Of Chicago$117,759,216
- Harold E Varmus · Sloan-Kettering Institute For Cancer Res$82,854,111
Research focus
TransplantationBloodInnovationBone Marrow TransplantationTechnologyMalignant NeoplasmsClinical ResearchAllogenicImmuneProphylactic TreatmentClinical TrialsChronic Graft Versus Host DiseaseDesignScienceCellsClinical Trials NetworkFutureHematologic NeoplasmsSiblingsHematological DiseasePreventionRegulatory T-LymphocyteBaseSafety
Grant awards (19)
Ustekinumab for Graft versus Host Disease Prevention (IND 144540)$876,984
R01 · FY2025 · FD
Blood and Marrow Transplant Clinical Trials Network (BMT CTN) - Core Clinical Centers - UG1$214,179
UG1 · FY2025 · HL · contact PI
Blood and Marrow Transplant Clinical Trials Network (BMT CTN) - Core Clinical Centers - UG1$214,179
UG1 · FY2024 · HL · contact PI
Ustekinumab for Graft versus Host Disease Prevention (IND 144540)$862,342
R01 · FY2023 · FD
Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)$206,400
UG1 · FY2023 · HL · contact PI
Ustekinumab for Graft versus Host Disease Prevention (IND 144540)$870,890
R01 · FY2022 · FD
Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)$206,400
UG1 · FY2022 · HL · contact PI
Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)$206,400
UG1 · FY2021 · HL · contact PI
Ustekinumab for Graft versus Host Disease Prevention (IND 144540)$488,317
R01 · FY2020 · FD
Ustekinumab for Graft versus Host Disease Prevention (IND 144540)$436,229
R01 · FY2020 · FD
Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)$206,400
UG1 · FY2020 · HL · contact PI
Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)$206,400
UG1 · FY2019 · HL · contact PI
Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)$196,080
UG1 · FY2018 · HL · contact PI
Adoptive Transfer of Donor Tregs Specific Against Host Alloantigens for Presentio$556,530
R01 · FY2017 · HL · contact PI
Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)$194,404
UG1 · FY2017 · HL · contact PI
DISCIS Study$119,137
R21 · FY2016 · HL
Biologic Markers of Chronic Graft vs. Host Disease Therapeutic Response$86,000
R03 · FY2016 · CA · contact PI
DISCIS Study$131,776
R21 · FY2015 · HL
Biologic Markers of Chronic Graft vs. Host Disease Therapeutic Response$84,250
R03 · FY2015 · CA · contact PI